MARKERS OF BONE METABOLISM DURING SHORT-TERM ADMINISTRATION OF THYROXINE IN HEALTHY-VOLUNTEERS

被引:17
作者
FREVERT, EU [1 ]
BIESTER, A [1 ]
MULLER, MJ [1 ]
SCHMIDTGAYK, H [1 ]
VONZURMUHLEN, A [1 ]
BRABANT, G [1 ]
机构
[1] ENDOCRINE LAB, HEIDELBERG, GERMANY
关键词
D O I
10.1530/eje.0.1310145
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the influence of L-thyroxine (L-T-4) treatment over 3 weeks on biochemical markers of bone turnover in 12 healthy young men (age 25.6 +/- 1.4 years, BMI: 22.6 +/- 2.5 kg/m(2)). Serum parameters indicating bone formation [bone Gla protein (BGP), carboxyterminal propeptide of type I procollagen (PICP), and bone-specific alkaline phosphatase (BAP)] and bone resorption [cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and the urinary excretion of pyridinoline (Pyr) and deoxypyridinoline (D-Pyr)] were measured before and after three weeks of treatment with 300 mu g LT(4)/d, T-3 and T-4 significantly increased and TSH decreased to almost undetectable levels even when measured with a third generation TSH assay. Markers of bone formation showed variable responses with a small but significant increase in BGP but not in PICP or BAP. In contrast, all parameters of bone resorption increased significantly with a good correlation between D-Pyr excretion and the serum parameter ICTP (r = 0.78, p < 0.0001). These changes in bone-turnover markers were not necessarily paralleled by comparable increments of other markers of tissue thyrotoxicosis (SHBG, pulse rate, VO2), suggesting a variability in tissue sensitivity. These rapid responding parameters, especially in the easily obtainable serum parameter ICTP, might be valuable tools in the evaluation of several states of thyroxine excess.
引用
收藏
页码:145 / 149
页数:5
相关论文
共 46 条
[1]  
AUWERX J, 1986, Q J MED, V60, P737
[2]   QUANTITATIVE-ANALYSIS OF THE PYRIDINIUM CROSSLINKS OF COLLAGEN IN URINE USING ION-PAIRED REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
BLACK, D ;
DUNCAN, A ;
ROBINS, SP .
ANALYTICAL BIOCHEMISTRY, 1988, 169 (01) :197-203
[3]   IONIZED AND TOTAL SERUM-CALCIUM AND PARATHYROID-HORMONE IN HYPERTHYROIDISM [J].
BURMAN, KD ;
MONCHIK, JM ;
EARLL, JM ;
WARTOFSKY, L .
ANNALS OF INTERNAL MEDICINE, 1976, 84 (06) :668-671
[4]   ASSESSMENT OF BONE-FORMATION BY BIOCHEMICAL MARKERS IN METABOLIC BONE-DISEASE - SEPARATION BETWEEN OSTEOBLASTIC ACTIVITY AT THE CELL AND TISSUE-LEVEL [J].
CHARLES, P ;
HASLING, C ;
RISTELI, L ;
RISTELI, J ;
MOSEKILDE, L ;
ERIKSEN, EF .
CALCIFIED TISSUE INTERNATIONAL, 1992, 51 (06) :406-411
[5]  
COINDRE JM, 1986, ARCH INTERN MED, V146, P48, DOI 10.1001/archinte.146.1.48
[6]  
DELMAS PD, 1991, J BONE MINER RES, V6, P639
[7]   A THERAPEUTIC DILEMMA - SUPPRESSIVE DOSES OF THYROXINE SIGNIFICANTLY REDUCE BONE-MINERAL MEASUREMENTS IN BOTH PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN WITH THYROID-CARCINOMA [J].
DIAMOND, T ;
NERY, L ;
HALES, I .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (06) :1184-1188
[8]   SERUM CONCENTRATION OF THE CROSS-LINKED CARBOXYTERMINAL TELOPEPTIDE OF TYPE-I COLLAGEN (ICTP) IS A USEFUL PROGNOSTIC INDICATOR IN MULTIPLE-MYELOMA [J].
ELOMAA, I ;
VIRKKUNEN, P ;
RISTELI, L ;
RISTELI, J .
BRITISH JOURNAL OF CANCER, 1992, 66 (02) :337-341
[9]   TRIIODOTHYRONINE STIMULATES PROLIFERATION OF OSTEOBLAST-LIKE CELLS IN SERUM-FREE CULTURE [J].
ERNST, M ;
FROESCH, ER .
FEBS LETTERS, 1987, 220 (01) :163-166
[10]   NEW BIOMARKERS OF BONE-RESORPTION [J].
EYRE, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (03) :A470-A470